بررسی اثر عصاره متانولی پگانوم هارمالا و هارمین بر آسیب بافتی ناشی از دیابت در کلیه رتهای نر نژاد ویستار
الموضوعات :
فروغ کجباف
1
(دانشجوی دکتری، گروه زیست‌شناسی، دانشگاه آزاد اسلامی، واحد علوم و تحقیقات، تهران، ایران)
شهربانو عریان
2
(استاد، گروه علوم جانوری، دانشکده علوم زیستی، دانشگاه خوارزمی، تهران، ایران)
رامش احمدی
3
(استادیار، گروه علوم جانوری، دانشکده علوم پایه، دانشگاه آزاد اسلامی، واحد قم، قم، ایران)
اکرم عیدی
4
(استاد، گروه زیست‌شناسی، دانشگاه آزاد اسلامی، واحد علوم و تحقیقات، تهران، ایران)
تاريخ الإرسال : 08 الثلاثاء , شوال, 1440
تاريخ التأكيد : 29 الإثنين , ذو القعدة, 1441
تاريخ الإصدار : 25 الجمعة , رجب, 1441
الکلمات المفتاحية:
کلیه,
دیابت,
رتهای نر نژاد ویستار,
هارمین,
آسیب بافتی,
عصاره متانولی پگانوم هارمالا,
ملخص المقالة :
هدف: از عوارض خطرناک دیابت، نفروپاتی دیابتی است که شیوع نسبتاً بالایی در بیماران دیابتی داشته و باعث نارسایی کلیه می شود. بررسی روند تخریب و مکانیسم‌‌های جلوگیری‌‌کننده از آن در جهت کاهش آسیب‌‌های بافتی مخصوصا با تیمار توسط گیاهان می تواند موضوع قابل تاملی باشد . مواد و روش‌ها: در این تحقیق اسپند با نام علمیPeganum harmala ، گیاهی از خانواده Zygophyllaceae و ماده موثره آن به نام هارمین در آسیب کلیوی ناشی از دیابت، بر روی 80 راس رت نر نژاد ویستار در گروه‌‌های تجربی و دیابتی تحت تیمار با عصاره متانولی دانه و برگ پگانوم هارمالا و نیز هارمین صورت گرفت. پس از انجام مراحل فیکس و پاساژ بافتی، لام‌‌های میکروسکوپی تهیه شده و مطالعه گردید. یافته‌ها: در بررسی‌‌های بافتی چهار فاکتور تغییرات اپی تلیالی، تخریب توبولی، التهاب لوکوسیتی و گرفتگی مویرگی در کلیه بررسی و مشخص شد، گروه رت دیابتی دریافت‌‌کننده هارمین و گروه رت دیابتی دریافت‌‌کننده عصاره دانه دچار تخریب و آسیب‌دیدگی کمتری شده است در حالی که در گروه رت دیابتی دریافت‌‌کننده عصاره برگ این آسیب‌‌ها بالاتر بود و جالب توجه بود که درگروه‌‌های تجربی هیچ اختلافی با گروه کنترل مثبت مشاهده نگردید. نتیجه‌گیری: طبق نتایج بافتی در تحقیق ما عصاره دانه و هارمین این توانایی را دارد که جلوی آسیب بافتی ناشی از دیابت را بگیرد که این را می‌توان به آلکالوئید هارمین موجود در دانه نسبت داد.
المصادر:
Gomez-Perez FJ, Aguilar-Salinas CA, Almeda-Valdes P, Cuevas-Ramos D, Lerman Garber I, Rull JA. HbA1c for the diagnosis of diabetes mellitus in a developing country. A position article. Archives of medical research. 2010; 41(4): 302-8.
Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest. 2005; 115(1): 86-93.
Asadikaram G, Asiabanha M, Sayadi A, Jafarzadeh A, Hassanshahi G. Impact of opium on the serum levels of TGF-beta in diabetic, addicted and addicted-diabetic rats. Iranian journal of immunology. 2010; 7(3): 186-92.
Prasad P, Tiwari AK, Kumar KMP, Ammini AC, Gupta A, Gupta R, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Medical Genetics. 2006; 7: (42)1-9.
Baek S-S, Kim S-H. Treadmill exercise ameliorates symptoms of Alzheimer disease through suppressing microglial activation-induced apoptosis in rats. J Exerc Rehabi. 2016; 12(6): 34-526. Ozbek E. Induction of oxidative stress in kidney. International journal of nephrology. DOI: 10.1155/2012/465897, Corpus ID: 6159429.
Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clinical science. 2009; 116(6): 479-92.
Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clinical science. 2013; 124(3): 139-52.
Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular therapeutics. 2012; 30(1): 49-59.
Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, et al. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. Journal of clinical lipidology. 2012; 6(1): 42-9.
Maritim AC, Sanders RA, Watkins J. Diabetes, oxidative stress, and antioxidants: A review. Journal of biochemical and molecular toxicology. 2003; 17: 24-38.
Zhang L, Yang J, Chen XQ, Zan K, Wen XD, Chen H, et al. Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. J Ethnopharmacol. 2010; 132(2): 518-24.
Loub WD, Farnsworth NR, Soejarto DD, Quinn ML. NAPRALERT: computer handling of natural product research data. Journal of chemical information and computer sciences. 1985; 25(2): 99-103.
Mahmoudian M, Rahbar N, Hoormand M, Ebrahimi SA, Madadkar Sobhani A. CYTOTOXICITY OF PEGANUM HARMALA L. SEEDS EXTRACT AND ITS RELATIONSHIP WITH CONTENTS OF ß-CARBOLINE ALKALOIDS. RJMS. 2002; 8(26): 432-7.
Mina CN, Farzaei MH, Gholamreza A. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 2015; 35(1): 104-9.
Bremner P, Rivera D, Calzado MA, Obon C, Inocencio C, Beckwith C, et al. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators. J Ethnopharmacol. 2009; 124(2): 295-305.
Tse SY, Mak IT, Dickens BF. Antioxidative properties of harmane and beta-carboline alkaloids. Biochemical pharmacology. 1991; 42(3): 459-64.
Herraiz T, Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke:
beta-carboline alkaloids act as potent and reversible inhibitors. Biochemical and biophysical research communications. 2005; 86(2): 326- 378.
Squires PE, Hills CE, Rogers GJ, Garland P, Farley SR, Morgan NG. The putative imidazoline receptor agonist, harmane, promotes intracellular calcium mobilisation in pancreatic beta-cells. European journal of pharmacology. 2004; 501(1-3): 31-9.
Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. Journal of neurochemistry. 2000; 75(2): 521-31.
Ahvazi M, Khalighi-Sigaroodi F, Charkhchiyan MM, Mojab F, Mozaffarian V-A, Zakeri H. Introduction of medicinal plants species with the most traditional usage in alamut region. Iran J Pharm Res. 2012; 11(1): 185-94.
Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1996; 16(20): 6394-401.
Moura DJ, Richter MF, Boeira JM, Pegas Henriques JA, Saffi J. Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities. Mutagenesis. 2007; 22(4): 293-302.
Fortunato JJ, Reus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Progress in neuro-psychopharmacology & biological psychiatry. 2009; 33(8): 1425-30.
Komeili G, Hashemi M, Bameri-Niafar M. Evaluation of Antidiabetic and Antihyperlipidemic Effects ofPeganum harmala Seeds in Diabetic Rats. Cholest .Volume 2016, Article ID: 7389864, DOI: https://doi.org/10.1155/2016/7389864.
Berdai MA, Labib S, Harandou M. Peganum harmala L. Intoxication in a Pregnant Woman. Case Reports in Emergency Medicine. Volume 2014, Article ID: 783236,
DOI: https://doi.org/10.1155/2014/783236
Réus GZ, Stringari RB, de Souza B, Petronilho F, Dal-Pizzol F, Hallak JE, et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxidative medicine and cellular longevity. 2010; 3(5): 325-31.
Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Current medicinal chemistry. 2010; 17(34): 4256-69.
Rezaei M, Nasri S, Roughani M, Niknami Z, Ziai SA. Peganum Harmala L. Extract Reduces Oxidative Stress and Improves Symptoms in 6-Hydroxydopamine-Induced Parkinson's Disease in Rats. Iran J Pharm Res. 2016; 15(1): 275-81.
Wang Y, Fu X, Wang X, Jia X, Gu X, Zhang J, et al. Protective effects of anisodamine on renal function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The Tohoku journal of experimental medicine. 2011; 224(2): 91-7.
Long M, Qiu D, Li F, Johnson F, Luft B. Flavonoid of Drynaria fortunei protects against acute renal failure. Phytotherapy research. 2005; 19(5): 422-7.
Mahmood S, Hadi A, Jawad Z, Mohamed S, Jawad Naki Z, Mahmood Jawad S, et al. Effect of repeated administration of Peganum harmala alcoholic extract on the liver and kidney in Albino mice: A histo-pathological study. Journal of Scientific & Innovative Research. 2013; 2 (3): 585-597.
Zhang J, Zhang Z. Cytotoxic and Apoptotic Activity of the Novel Harmine Derivative ZC-14 in Sf9 Cells. Int J Mol Sci. 2018; 19(3): 811-24. doi: 10.3390/ijms19030811.
Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao XL, et al. Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary & pancreatic diseases international. 2011; 10(6): 599-604.
Salahshoor MR, Mahmoudian ZG, Roshankhah S, Farokhi M, Jalili C. Harmine shows therapeutic activity on Nicotine-induced liver failure in mice. Histology and histopathology. 2019: 10(97): 1-7.
_||_
Gomez-Perez FJ, Aguilar-Salinas CA, Almeda-Valdes P, Cuevas-Ramos D, Lerman Garber I, Rull JA. HbA1c for the diagnosis of diabetes mellitus in a developing country. A position article. Archives of medical research. 2010; 41(4): 302-8.
Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest. 2005; 115(1): 86-93.
Asadikaram G, Asiabanha M, Sayadi A, Jafarzadeh A, Hassanshahi G. Impact of opium on the serum levels of TGF-beta in diabetic, addicted and addicted-diabetic rats. Iranian journal of immunology. 2010; 7(3): 186-92.
Prasad P, Tiwari AK, Kumar KMP, Ammini AC, Gupta A, Gupta R, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Medical Genetics. 2006; 7: (42)1-9.
Baek S-S, Kim S-H. Treadmill exercise ameliorates symptoms of Alzheimer disease through suppressing microglial activation-induced apoptosis in rats. J Exerc Rehabi. 2016; 12(6): 34-526. Ozbek E. Induction of oxidative stress in kidney. International journal of nephrology. DOI: 10.1155/2012/465897, Corpus ID: 6159429.
Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clinical science. 2009; 116(6): 479-92.
Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clinical science. 2013; 124(3): 139-52.
Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular therapeutics. 2012; 30(1): 49-59.
Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, et al. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. Journal of clinical lipidology. 2012; 6(1): 42-9.
Maritim AC, Sanders RA, Watkins J. Diabetes, oxidative stress, and antioxidants: A review. Journal of biochemical and molecular toxicology. 2003; 17: 24-38.
Zhang L, Yang J, Chen XQ, Zan K, Wen XD, Chen H, et al. Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. J Ethnopharmacol. 2010; 132(2): 518-24.
Loub WD, Farnsworth NR, Soejarto DD, Quinn ML. NAPRALERT: computer handling of natural product research data. Journal of chemical information and computer sciences. 1985; 25(2): 99-103.
Mahmoudian M, Rahbar N, Hoormand M, Ebrahimi SA, Madadkar Sobhani A. CYTOTOXICITY OF PEGANUM HARMALA L. SEEDS EXTRACT AND ITS RELATIONSHIP WITH CONTENTS OF ß-CARBOLINE ALKALOIDS. RJMS. 2002; 8(26): 432-7.
Mina CN, Farzaei MH, Gholamreza A. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 2015; 35(1): 104-9.
Bremner P, Rivera D, Calzado MA, Obon C, Inocencio C, Beckwith C, et al. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators. J Ethnopharmacol. 2009; 124(2): 295-305.
Tse SY, Mak IT, Dickens BF. Antioxidative properties of harmane and beta-carboline alkaloids. Biochemical pharmacology. 1991; 42(3): 459-64.
Herraiz T, Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke:
beta-carboline alkaloids act as potent and reversible inhibitors. Biochemical and biophysical research communications. 2005; 86(2): 326- 378.
Squires PE, Hills CE, Rogers GJ, Garland P, Farley SR, Morgan NG. The putative imidazoline receptor agonist, harmane, promotes intracellular calcium mobilisation in pancreatic beta-cells. European journal of pharmacology. 2004; 501(1-3): 31-9.
Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. Journal of neurochemistry. 2000; 75(2): 521-31.
Ahvazi M, Khalighi-Sigaroodi F, Charkhchiyan MM, Mojab F, Mozaffarian V-A, Zakeri H. Introduction of medicinal plants species with the most traditional usage in alamut region. Iran J Pharm Res. 2012; 11(1): 185-94.
Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1996; 16(20): 6394-401.
Moura DJ, Richter MF, Boeira JM, Pegas Henriques JA, Saffi J. Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities. Mutagenesis. 2007; 22(4): 293-302.
Fortunato JJ, Reus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Progress in neuro-psychopharmacology & biological psychiatry. 2009; 33(8): 1425-30.
Komeili G, Hashemi M, Bameri-Niafar M. Evaluation of Antidiabetic and Antihyperlipidemic Effects ofPeganum harmala Seeds in Diabetic Rats. Cholest .Volume 2016, Article ID: 7389864, DOI: https://doi.org/10.1155/2016/7389864.
Berdai MA, Labib S, Harandou M. Peganum harmala L. Intoxication in a Pregnant Woman. Case Reports in Emergency Medicine. Volume 2014, Article ID: 783236,
DOI: https://doi.org/10.1155/2014/783236
Réus GZ, Stringari RB, de Souza B, Petronilho F, Dal-Pizzol F, Hallak JE, et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxidative medicine and cellular longevity. 2010; 3(5): 325-31.
Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Current medicinal chemistry. 2010; 17(34): 4256-69.
Rezaei M, Nasri S, Roughani M, Niknami Z, Ziai SA. Peganum Harmala L. Extract Reduces Oxidative Stress and Improves Symptoms in 6-Hydroxydopamine-Induced Parkinson's Disease in Rats. Iran J Pharm Res. 2016; 15(1): 275-81.
Wang Y, Fu X, Wang X, Jia X, Gu X, Zhang J, et al. Protective effects of anisodamine on renal function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The Tohoku journal of experimental medicine. 2011; 224(2): 91-7.
Long M, Qiu D, Li F, Johnson F, Luft B. Flavonoid of Drynaria fortunei protects against acute renal failure. Phytotherapy research. 2005; 19(5): 422-7.
Mahmood S, Hadi A, Jawad Z, Mohamed S, Jawad Naki Z, Mahmood Jawad S, et al. Effect of repeated administration of Peganum harmala alcoholic extract on the liver and kidney in Albino mice: A histo-pathological study. Journal of Scientific & Innovative Research. 2013; 2 (3): 585-597.
Zhang J, Zhang Z. Cytotoxic and Apoptotic Activity of the Novel Harmine Derivative ZC-14 in Sf9 Cells. Int J Mol Sci. 2018; 19(3): 811-24. doi: 10.3390/ijms19030811.
Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao XL, et al. Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary & pancreatic diseases international. 2011; 10(6): 599-604.
Salahshoor MR, Mahmoudian ZG, Roshankhah S, Farokhi M, Jalili C. Harmine shows therapeutic activity on Nicotine-induced liver failure in mice. Histology and histopathology. 2019: 10(97): 1-7.
